Skip to content
DefDex

Federal award

CEPHEID

W81K0216P0319

Contract

Obligated and Ceiling

Obligated (net)
$303,087.60
Ceiling (potential value, not spending)
$404,116.80
Current value
$303,087.60
Gross positive obligations
$404,116.80

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
CEPHEID · W6HQTMWB9Q28
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
DANAHER CORPORATION · MBFSJ8M4RQB6
Awarding agency
Department of War · sub-agency 2100 · office W81K02
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W81K0216P0319
Award type code
B
Actions
12 · Sep 21, 2016 to Feb 25, 2020
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History12

Award actions
DateFYModAction typeObligationCompany in company totals
Feb 25, 2020FY2020P00011F−$101,029.20
—
Nov 4, 2019FY2020P00010C$101,029.20
—
May 30, 2019FY2019P00009G$0.00
—
Jan 23, 2019FY2019P00008G$101,029.20
—
Dec 14, 2018FY2019P00007C$0.00
—
Jun 19, 2018FY2018P00006G$0.00
—
Oct 13, 2017FY2018P00005C$101,029.20
—
Aug 23, 2017FY2017P00004G$0.00
—
Nov 29, 2016FY2017P00003D$0.00
—
Nov 28, 2016FY2017P00002D$8,984.40
—
Oct 21, 2016FY2017P00001D$92,044.80
—
Sep 21, 2016FY20160—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.